News
Exact Sciences
EXAS · NASDAQ
Price unavailable right now.
No price history for this range.
Latest news
- Press releaseBusiness Wire
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
- Press releaseBusiness Wire
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
- Press releaseBusiness Wire
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
- Press releaseBusiness Wire
Exact Sciences Stockholders Approve Acquisition by Abbott
- News
Exact Sciences Earnings Review: Q4 Summary
- Press releaseBusiness Wire
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
- Press releaseBusiness Wire
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
- Press releaseBusiness Wire
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--JHG, FOLD, RAPT, and EXAS
- NewsVandana Singh
Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
- News
Assessing Exact Sciences: Insights From 16 Financial Analysts
- Press releasePRNewswire
Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
- Press releaseBusiness Wire
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
- Press releasePRNewswire
Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights
- Press releasePRNewswire
Halper Sadeh LLC Encourages EXAS, SOAR, BTBD Shareholders to Contact the Firm to Discuss Their Rights
- NewsAvi Kapoor
Top 2 Health Care Stocks That May Crash In Q1
- Press releasePRNewswire
Smart Oncology: 5 Stocks Chasing the $317B Prize
- News
Exact Sciences Enrolls First Patient In CRANE Trial In Japan To Evaluate Multi-Cancer Early Detection Test
- Press releaseBusiness Wire
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
- NewsVandana Singh
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal?
- NewsAvi Kapoor
Top 2 Health Care Stocks You May Want To Dump This Month
- Press releasePRNewswire
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
- Press releasePRNewswire
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN
- NewsAvi Kapoor
This Coinbase Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
- Press releasePRNewswire
Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights
- Press releaseBusiness Wire
Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium
- Press releaseBusiness Wire
Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
- NewsAnthony Noto
Deal Dispatch: Abbott, TPG And Lonza Make Major Moves, M&M Custard And New Fortress Energy Struggle
- Press releasePRNewswire
Halper Sadeh LLC Encourages CIVI, JAMF, EXAS Shareholders to Contact the Firm to Discuss Their Rights
- Press releaseBusiness Wire
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
- NewsPiero Cingari
Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday?
- Press releasePRNewswire
Shareholder Alert: The Ademi Firm investigates whether Exact Sciences Corporation is obtaining a Fair Price for its Public Shareholders
- NewsAvi Kapoor
Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday
- NewsVandana Singh
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics
- Press releaseBusiness Wire
EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders
- Press releasePRNewswire
Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
- Press releaseBusiness Wire
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome's Blood-Based Colorectal Cancer Screening Tests
- Press releaseBusiness Wire
Exact Sciences Announces Third Quarter 2025 Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.